Glimicut MV 2mg/500mg/0.2mg Tablet SR
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimicut MV 2mg/500mg/0.2mg Tablet SR
Diabetic patients may benefit from the anti-diabetic medication, Glimicut MV 2mg/500mg/0.2mg Tablet SR, a combined-drug formulation for managing type 2 diabetes in adults. This medication aids in blood sugar regulation. Administer this extended-release tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood glucose monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (fast-acting glucose sources). Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential.
Primary Ingredients of Glimicut MV 2mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Glimicut MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimicut MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimicut MV 2mg/500mg/0.2mg sustained-release tablet should be taken on an empty stomach.
Common Side effects of Glimicut MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimicut MV 2mg/500mg/0.2mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicut MV 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Glimicut MV 2mg/500mg/0.2mg Tablet SR works:
Extended-release Glimicut MV tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimicut MV 2mg/500mg/0.2mg SR tablets with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicut MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimicut MV tablets (2mg/500mg/0.2mg) are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The extended-release Glimicut MV 2mg/500mg/0.2mg tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Glimicut MV 2mg/500mg/0.2mg SR tablets. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimicut MV 2mg/500mg/0.2mg Tablet SR :
Should you forget a dose of Glimicut MV 2mg/500mg/0.2mg SR Tablet, administer it immediately if feasible. Otherwise, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimicut MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently